Advertisement

Topics

Companies Related to "Innovations portfolio company Cell Medica granted Fast Track" [Most Relevant Company Matches] - Page: 4 RSS

17:31 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Innovations portfolio company Cell Medica granted Fast Track" found in our extensive corporate database of over 50,000 company records.

Showing "Innovations portfolio company Cell Medica granted Fast Track" Companies 76–100 of 8,300+

Relevant

Neurotech Pharmaceuticals, Inc.

Neurotech is developing sight-saving therapeutics for the treatment of chronic retinal diseases. The Company's lead product candidate, NT-501, is currently in late-stage clinical development for advanced dry age-related macular degeneration (dry AMD) and retinitis pigmentosa (RP). The Company's portfolio of product candidates also includes treatments for wet AMD. All of Neurotech's development pro...


BreathableBaby, LLC

BreathableBaby is dedicated to developing breathable innovations that address parents’ concerns for baby’s safety and comfort inside the crib. The recipient of numerous awards for creative innovations in making the crib environment safer for babies, the company began out of a need in the market for products that were safer and competitively priced. ...

Ncardia

Ncardia (www.ncardia.com) believes that stem cell technology will help to get better medicines to patients faster. The company develops, produces and commercializes highly predictive human cellular assay systems for safety and efficacy testing. The cardiac product portfolio encompasses a broad panel of hiPSC derived Cardiomyocytes (Pluricyte®, Cor.4UÂ...


NextGen Sciences Limited

NextGen Sciences Limited is a fast track platform technology development company, specialising in the field of genomics, transcriptomics and proteomics.Our technologies, which include hardware, software and the associated biochemistries are used to create and enhance scientific and drug discovery knowledge.

T2 Biosystems

T2 Biosystems is a private biotechnology company developing next-generation medical diagnostic products using its proprietary technology, combining nanotechnology and miniaturized magnetic resonance (MR) technology to provide rapid, accurate and portable diagnostics. T2 Biosystems was founded in 2006 by renowned researchers from the Massachusetts Institute...

DiscoveRx® Corporation

Founded in 2000, DiscoveRx is a privately held, venture-backed company headquartered in Fremont, California, with an additional office in Birmingham, England. The Company pioneered the use of β-galactosidase enzyme fragment complementation in biochemical and cell based assays for discovery research, and holds extensive intellectual property in this area...

Connecticut Innovations

The Connecticut Legislature created Connecticut Innovations (CI) in 1989 and charged it with growing Connecticut's entrepreneurial, technology economy by making venture and other investments. By building a vibrant technology community in the state, Connecticut Innovations creates substantial, long-term economic opportunity for Connecticut citizens.

Cell Pathways Incorporated

Cell Pathways is a pharmaceutical company focused on the research, development and commercialization of products to prevent cancer and to treat cancer. Cell Pathways' technology may also prove to have applicability beyond the field of cancer.Cell Pathways' technology is based upon its discovery of a novel mechanism which the Company believes, based on its research, can be targeted to induce select...

Essen BioScience, Inc.

Essen BioScience, based in Ann Arbor, MI, is a leading provider of critical analytical instrumentation, software, reagents and services used in cell-based life sciences research. Essen was founded in 1999 by Kirk Schroeder and Brad Neagle who have previously been responsible for “best/first in class” innovations in the field of cell-based in-vitro ...

Circassia Ltd

Circassia is a specialty biopharmaceutical company focused on developing world-class immunotherapies. These include a new class of T-cell vaccines designed to treat a broad range of allergies, and therapies to combat autoimmune conditions such as rheumatoid arthritis and psoriasis. The Company has made rapid progress since its establishment in 2006, and several of its products are currently in m...

China Biopharma

China Biopharma Inc. (Stock Symbol: CBPC.OB) is a fast growing provider of human vaccine products in China. Through its wholly owned subsidiary, China Biopharma Limited, the Company owns the majority interest of Zhejiang Tianyuan Biotech Co., Ltd. The Company's current products consist of human vaccines against influenza (flu), epidemic hemorrhagic fever (HF), and Japanese Encephalitis (JE). With ...

Post-n-Track

Post-n-Track is an information logistics provider for healthcare management, enabling payers, providers, health systems and vendors to securely manage, control and optimize the flow of health information. Post-n-Track aligns the business value of information with the appropriate expertise, infrastructure, communication channels, transaction standards, busi...

ORFLO Technologies

ORFLO (www.orflo.com) is a life sciences company developing and marketing revolutionary instrumentation protein and cell analysis. At the core of ORFLO’s instrumentation is a patent protected disposable, micro-fluidic, electronic optic flow cell. ORFLO’s instruments provide a powerful unique window to cell analysis by directly measuring fluoresce...

EntreMed Incorporated

EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them. EntreMed is focused on developing drugs that are safe and convenient, and provide the potential for improved patient outcomes. EntreMed’s goal is to develop and commercialize therapeutics based on the Company...

Behavioral Innovations

Established in 2000, Behavioral Innovations is the first provider in the Dallas/Fort Worth area to offer on-site ABA treatment and establish an office for consultations. The qualified professionals help children who have been diagnosed with Autism, Asperger's, Cerebral Palsy, Down Syndrome, and other developmental and behavioral disorders. Behavioral Innovations is one of the largest private emplo...

BrainStorm Cell Therapeutics, Inc.

BrainStorm Cell Therapeutics Inc. is a promising company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases. The Company holds rights to develop and commercialize the technology through an exclusive, worldwide licensing agreement with Ramot at Tel Aviv Universit...

Fast Company

Fast Company magazine is celebrating its 10th anniversary. Launched in November 1995 by Alan Webber and Bill Taylor, two former Harvard Business Review editors, the magazine was founded on a single premise: A global revolution was changing business, and business was changing the world. Fast Company set out to chronicle how a new breed of companies create and compete, to highlight new business prac...

Entest BioMedical Inc.

Entest BioMedical Inc. (OTC Bulletin Board: ENTB) is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTC Bulletin Board: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), immuno-cancer therapies, testing procedures for diabetes, stem cell research applications for diabetes and other illnesses. The C...

Harpoon Therapeutics, Inc.

Harpoon Therapeutics is an immuno-oncology company founded by Patrick Baeuerle, Ph.D., a pioneer in the development of T-cell engaging therapies, and MPM Capital. The company is focused on the discovery and development of novel T-cell engaging biologics for the treatment of cancer and other diseases. Harpoon Therapeutics created a novel T-cell recruiting d...

Oy Faron Pharmaceuticals LTD.

Faron Pharmaceuticals Ltd. ("Faron") is a drug discovery and drug development service company. It was founded by a group of R&D professionals, and joined by business and legal advisors with excellent track records.Faron has very good connections to research groups at non-commercial environments, e.g. at universities, in which the majority of new biomedical innovations are made nowadays. Faron's st...

Ore Pharmaceutical Holdings Inc.

Ore Pharmaceutical Holdings Inc. (the “Company”) is a pharmaceutical asset management company. The Company acquires interests in pharmaceutical assets whose value, it believes, it can significantly enhance through targeted development, with the goal of then monetizing these assets through sales or out-licensing transactions. The Company currently...

Celtaxsys, Inc.

Celtaxsys is privately-held start-up focused on discovery and development of therapeutics to treat inflammation. The Company has identified a portfolio of immunoregulators that redirect immune cell migration and activation. Initial product candidates can ameliorate acute and chronic inflammatory disorders of cutaneous, and other, barrier epithelia.

X4 Pharmaceuticals

X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and increase the ability for T-cells to track and destroy cancer cells. The company’s oral small molecule drug candidates inhibit the CXCR4 receptor, a pathway which plays a central role in promoting the immunosuppressive and pro-angiogenic microenvironment...

Cell Essentials, Inc.

Cell Essentials provides contract cell biology-based services facilitating the creation of reagents for use in diagnostics and drug discovery as well as basic research. Major services include the development of custom hybridomas and production of monoclonal antibodies, large scale cell culture, stable cell line development, cell-based assay development, cell banking, and peptide synthesis. Adenovi...

Nycomed

Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused on branded medicines in gastroenterology, respiratory diseases, inflammation diseases, pain, osteoporosis and tissue management. Its R&D is built to be open for partnerships also beyond its core areas in inflammatory, respiratory diseases and pain as in-licensing is a cornerstone in the company’s ...


More From BioPortfolio on "Innovations portfolio company Cell Medica granted Fast Track"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks